Archive

Green light for 10 new medicines in November 2025

Written by Gary Finnegan | 7 Dec 2025

The European Medicines Agency’s key committee on human medicines (CHMP) recommended ten medicines for approval at its November 2025 meeting. This brings to 97 the total number of… read more.

Pazopanib shows promise as Ewing’s sarcoma treatment

Written by Bruce Sylvester | 24 Oct 2025

Researchers report success in using pazopanib to treat young patients diagnosed with deadly Ewing’s sarcoma. They published their findings on Oct. 23, 2025 in Frontiers in Oncology As… read more.

UGA researchers develop alternative to alcohol-based hand sanitizers

Written by Charlie King | 19 Aug 2025

University of Georgia researchers have developed a new type of hand sanitizer that eliminates more than 97% of bacteria and fungi, including antibiotic-resistant strains. The new gel provides an alternative… read more.

Dalbavancin shows promise for Staphylococcus aureus bloodstream infections

Written by Bruce Sylvester | 16 Aug 2025

Researchers report that treating complicated Staphylococcus aureus bloodstream infections with two intravenous (IV) doses of the antibiotic dalbavancin seven days apart is as effective as treatment with daily… read more.

FDA-approved drugs could make nano-medicine safer, study finds

Written by Charlie King | 14 Jul 2025

An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in… read more.

A repurposed FDA-approved drug shows promise in killing antibiotic resistant bacteria

Written by Charlie King | 19 Jun 2025

A new study from Emory University addresses the growing global crisis of antibiotic-resistant infections. Many of these drug-resistant bacteria are spread through hospitals, and there are few antibiotics… read more.

Adjunctive zilebesiran shows efficacy in uncontrolled hypertension

Written by Bruce Sylvester | 29 May 2025

Among patients with ongoing, uncontrolled hypertension in spite of treatment with indapamide, amlodipine, or olmesartan, the addition of a single dose of investigative zilebesiran has, at 3 months,… read more.

Green light for 16 new medicines in the EU

Written by Gary Finnegan | 22 May 2025

April was a bumper month for drug approvals in Europe, with sixteen new products recommended by the European Medicines Agency’s (EMA) key committee on human medicines. This almost… read more.

Methotrexate emerges as alternative first-line treatment for pulmonary sarcoidosis

Written by Bruce Sylvester | 19 May 2025

While prednisone is the standard first-line treatment for pulmonary sarcoidosis, side effects can diminish quality of life. Researchers report that methotrexate appears to have fewer side effects and… read more.

A repurposed anti-inflammatory drug may help treat alcohol use disorder and related pain

Written by Charlie King | 2 May 2025

A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity—two issues… read more.

Researchers may have solved decades-old mystery behind benzodiazepine side effects

Written by Charlie King | 21 Apr 2025

Benzodiazepines like Valium and Xanax are often prescribed to treat anxiety, insomnia and seizures. While these drugs can be effective as a short-term treatment, researchers are trying to… read more.

Use of antidepressant medication linked to substantial increase in risk of sudden cardiac death

Written by Charlie King | 8 Apr 2025

Sudden cardiac death (SCD) refers to an unexpected death of a person, believed to be caused by a heart-related issue. It occurs within one hour of the onset… read more.

1 2 3 … 6 Next »

Archive

Subscribe for our mailing list

Follow Us